Effect of different imputation approaches on the evaluation of radiographic progression in patients with psoriatic arthritis: Results of the RAPID-PsA 24-week phase III double-blind randomised placebo-controlled study of certolizumab pegol

D. Van Der Heijde, R. Fleischmann, J. Wollenhaupt, A. Deodhar, D. Kielar, F. Woltering, C. Stach, B. Hoepken, T. Arledge, P. J. Mease

Research output: Contribution to journalArticlepeer-review

64 Scopus citations

Fingerprint

Dive into the research topics of 'Effect of different imputation approaches on the evaluation of radiographic progression in patients with psoriatic arthritis: Results of the RAPID-PsA 24-week phase III double-blind randomised placebo-controlled study of certolizumab pegol'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds